BriefTea
Every story in sixty words
Get the free app no ads · no paywallExplained in plain English
Foundayo is highlighted as Europe's first approved daily pill for obesity and type 2 diabetes. This signifies a new type of treatment option for these conditions. While other treatments exist, including injectables, a daily pill could offer a more convenient and potentially more accessible option for many people across Europe.
Stories that explain this
Foundayo, Eli Lilly's new daily pill, approved for UK weight lossRelated explainers
Who is Eli Lilly? Will the NHS pay for it? What are weight loss jabs? Why is UK first in Europe? Why build EVs in Europe? Why is daily bed-making recommended? Your daily life from space What are daily limits?The full catalogue
Browse every card filed under E →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.